The aggregation of one of these client proteins, the microtubule-associated protein tau (tau), is thought to contribute to disease progression in multiple neurodegenerative diseases, including Alzheimer’s disease (AD) and frontotemporal dementia (FTD) [29,30]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.